Fig. 3From: Disease modification and Neuroprotection in neurodegenerative disordersDelayed start design (a). The delayed treatment group (3) does not catch up with the early treatment group (2). (1) is the untreated, placebo group. Staggered withdrawal design (b). The withdrawn group (3) does not decline to the level of the placebo group (1)Back to article page